COST-EFFECTIVENESS OF TIOTROPIUM VERSUS GLYCOPYRRONIUM IN MODERATE TO VERY SEVERE COPD IN FRANCE

被引：0
|
作者：
Eklund, O. [1 ]
Borgstrom, F. [2 ]
Lindh, M. [1 ]
Detournay, B. [3 ]
Setton, M. [4 ]
Le Lay, K. [4 ]
机构：
[1] Quantify Res, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Cemka Eval, Bourg La Reine, France
[4] Boehringer Ingelheim France, Paris, France
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1208
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS40
引用
收藏
页码：A555 / A555
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe COPD in France
    Eklund, Oskar
    Borgstrom, Fredrik
    Lindh, Maria
    Laurendeau, Caroline
    Detournay, Bruno
    Luciani, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [2] COST-EFFECTIVENES OF TIOTROPIUM VS GLYCOPYRRONIUM IN MODERATE TO VERY SEVERE COPD IN SPAIN
    Eklund, O.
    Afzal, F.
    Borgstrom, F.
    Ojanguren, M. E.
    Crespo, C.
    Baldwin, M.
    VALUE IN HEALTH, 2015, 18 (07) : A501 - A501
  • [3] Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
    Eklund, Oskar
    Afzal, Faraz
    Borgstrom, Fredrik
    Flavin, Jason
    Ternouth, Andrew
    Ojanguren, Maria Eugenia
    Crespo, Carlos
    Baldwin, Mike
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 243 - 252
  • [4] COST-EFECTIVENESS OF TIOTROPIUM VS GLYCOPYRRONIUM IN MODERATE TO VERY SEVERE COPD IN CANADA, SWEDEN AND THE UK
    Eklund, O.
    Afzal, F.
    Borgstrom, F.
    Flavin, J.
    Ternouth, A.
    Baldwin, M.
    VALUE IN HEALTH, 2015, 18 (03) : A173 - A174
  • [5] COST-EFFECTIVENESS OF GLYCOPYRRONIUM COMPARED TO TIOTROPIUM IN COPD PATIENTS FROM A SWEDISH SOCIETAL PERSPECTIVE
    Costa-Scharplatz, M.
    Tambour, M.
    Henriksson, F.
    Stallberg, B.
    VALUE IN HEALTH, 2013, 16 (07) : A371 - A372
  • [6] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In Severe To Very Severe COPD: The Spark Study
    Wedzicha, J. A.
    Decramer, M.
    Ficker, J.
    Niewoehner, D. E.
    Sandstrom, T.
    Taylor, A. Fowler
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Superiority Of Glycopyrronium Versus Tiotropium In Early Onset Of Bronchodilation In Patients With Moderate To Severe COPD - The Fast Study
    Watz, H.
    Mailaender, C.
    Kirsten, A. -M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial
    Hoogendoorn, Martine
    Al, Maiwenn J.
    Beeh, Kai-Michael
    Bowles, David
    von der Schulenburg, J. Matthias Graf
    Lungershausen, Juliane
    Monz, Brigitta U.
    Schmidt, Hendrik
    Vogelmeier, Claus
    Rutten-van Molken, Maureen P. M. H.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (03) : 556 - 564
  • [9] Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK
    Kendall, Robyn
    Martin, Alan A.
    Shah, Dhvani
    Shukla, Soham
    Compton, Chris
    Ismaila, Afisi S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 1815 - 1825
  • [10] SUPERIORITY OF GLYCOPYRRONIUM VERSUS TIOTROPIUM IN EARLY ONSET OF BRONCHODILATION IN PATIENTS WITH MODERATE TO SEVERE COPD - THE FAST STUDY
    Watz, H.
    Mailaender, C.
    Kirsten, A-M
    THORAX, 2015, 70 : A140 - A140
12345